Lactulose: Clinical Trials

8 trials of Lactulose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 terminated. 8 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow Lactulose: new trials by email Literature Review of Lactulose trials Research Report on Lactulose

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Lactulose - Cancer
Phase 1 / Phase 2RecruitingUniversity of Chicago552026-12-152026-06-16
Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
Branch Chain Amino Acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure
Phase 1CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1822023-01-172026-11-17
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
Branched chain amino acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure
Phase 1CompletedPost Graduate Institute of Medical Education and Research, Chandigarh702019-11-012022-08-16
Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants
Lactulose and Mannitol solution, Sucralose - Burns
Phase 1TerminatedGlaxoSmithKline182018-01-292019-08-19
Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability
12C mannitol, Indomethacin, 13C mannitol - Impaired Small Intestinal Permeability
Phase 1CompletedMayo Clinic252015-08-012019-06-04
Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.
Metformin, Placebo - Insulin Resistance, Prediabetic State
Phase 1CompletedMayo Clinic122013-10-012017-09-01
Kristalose as Bowel Evacuant Prior to Colonoscopy
Kristalose - Bowel Evacuant Prior to Colonoscopy
Phase 1CompletedBenaroya Research Institute202010-12-012011-10-06
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
6β-Naltrexol escalating doses from 0.05-0.5 mg IV - Opiate Addiction
Phase 1CompletedCalifornia Pacific Medical Center Research Institute82009-03-012009-09-16

Conditions studied

Acute-On-Chronic Liver Failure (2)  ·  Hepatic Encephalopathy (2)  ·  Brain Edema (1)  ·  Burns (1)  ·  Insulin Resistance (1)  ·  Neoplasms (1)  ·  Opioid-Related Disorders (1)  ·  Prediabetic State (1)

Sponsors

Mayo Clinic (2)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  Benaroya Research Institute (1)  ·  California Pacific Medical Center Research Institute (1)  ·  GlaxoSmithKline (1)  ·  University of Chicago (1)

Countries

United States (5)  ·  India (2)  ·  United Kingdom (1)

Top investigators

Daniel Olson (1)  ·  John E Mendelson, MD (1)  ·  K Nair, MD, PhD (1)  ·  Madhumita Premkumar, MD, DM (1)  ·  Madhusudan Grover, MBBS (1)

Results publications

PMID 25715177, PMID 30568347, PMID 37975059, PMID 6749458, PMID 818729